RecruitingNCT07484971

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Sponsor

Société Algérienne de Formation et Recherche en Oncologie

Enrollment

2,000 participants

Start Date

Jul 21, 2025

Study Type

OBSERVATIONAL

Conditions

Prostate Cancer Prostate Cancer Metastatic Prostate Cancer (Adenocarcinoma)Prostate Cancer (Post Prostatectomy)Prostate Cancer (Diagnosis)Prostate Cancer Patients Treated by Radiotherapy

Summary

The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer. It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.

Eligibility

Sex: MALEMin Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with prostate cancer, prostate cancer (adenocarcinoma), and other related conditions. The study is currently recruiting participants at 24 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(24)

CAC Adrar - Oncology Department

Adrar, Algeria, Algeria

CAC Adrar - Radiotherapy Department

Adrar, Algeria, Algeria

CAC BLIDA - Oncology Department

Algiers, Algeria, Algeria

Centre Pierre et Marie Curie - Oncology Department

Algiers, Algeria, Algeria

Centre Pierre et Marie Curie - Radiology Department

Algiers, Algeria, Algeria

CHU Bab El Oued

Algiers, Algeria, Algeria

CHU Béni Messous - Oncology Departement

Algiers, Algeria, Algeria

EPH ROUIBA - Oncology Department

Algiers, Algeria, Algeria

CAC Annaba - Oncology Departement

Annaba, Algeria, Algeria

CAC Annaba - Radiotherapy Department

Annaba, Algeria, Algeria

CAC Annaba - Urology Departement

Annaba, Algeria, Algeria

CAC Bida - Radiotherapy Department

Blida, Algeria, Algeria

CAC BLIDA - Urology Department

Blida, Algeria, Algeria

CHU Constantine - Oncology Departement

Constantine, Algeria, Algeria

EH Constantine - Oncology Departement

Constantine, Algeria, Algeria

EPH Mostaghanem - Oncology Department

Mostaganem, Algeria, Algeria

CAC ORAN - Oncology Department

Oran, Algeria, Algeria

CAC ORAN - Radiotherapy Department

Oran, Algeria, Algeria

EHU ORAN - Oncology Department

Oran, Algeria, Algeria

EHU ORAN - Urology Department

Oran, Algeria, Algeria

CAC Sétif - Oncology Departement

Sétif, Algeria, Algeria

CAC Sétif - Radiotherapy Department

Sétif, Algeria, Algeria

EPH Sidi Ghilès - Oncology Department

Tipasa, Algeria, Algeria

CAC Draa Ben Khedda - Radiotherapy Departement

Tizi Ouzou, Algeria, Algeria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07484971

Related Trials

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

NCT060968701 location

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

NCT0685527788 locations

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

NCT0654594218 locations

IDOV-Immune for Advanced Solid Tumors

NCT069106575 locations

PSMA PET Combined With MRI for the Detection of PCa

NCT0705221418 locations